Business Standard

Scientists question validity of major hydroxychloroquine study

A spokeswoman for Mandeep R Mehra, the Harvard professor who was the paper's lead author, said on Friday that the study's authors had asked for an independent academic review and audit of their work.

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

Use of the malaria drugs chloroquine and hydroxychloroquine to prevent and treat Covid-19 has been a focus of intense public attention.

Roni Caryn Rabin | NYT
More than 100 scientists and clinicians have questioned the authenticity of a massive hospital database that was the basis for an influential study published last week that concluded that treating people who have Covid-19 with chloroquine and hydroxy-chloroquine did not help and might have increased the risk of abnormal heart rhythms and death.

In an open letter to The Lancet’s editor, Richard Horton, and the paper’s authors, the scientists asked the journal to provide details about the provenance of the data and called for the study to be independently validated by the World Health Organization or another institution.

A spokeswoman for  Mandeep

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 31 2020 | 1:45 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com